| dc.creator |
Kılıç, Faruk |
|
| dc.creator |
Şirin, Fevziye Burcu |
|
| dc.creator |
Şimşek, Fulya |
|
| dc.creator |
Bozkurt, Mustafa |
|
| dc.creator |
Işık, Ümit |
|
| dc.creator |
Aktepe, Evrim |
|
| dc.date |
2021-10-01T00:00:00Z |
|
| dc.identifier |
678bc9d0-d634-4e1a-bc4c-bb437f5815c0 |
|
| dc.identifier |
10.1007/s10803-020-04820-w |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/678bc9d0-d634-4e1a-bc4c-bb437f5815c0/oai |
|
| dc.description |
The aim of this study was to determine whether serum VEGF, IGF-1, and HIF-1 alpha levels differed between Autism Spectrum Disorder (ASD) patients and healthy controls. A total of 40 children with ASD and 40 healthy controls aged 4-12 years were included. Serum levels of VEGF, IGF-1, and HIF-1 alpha were measured using commercial enzyme-linked immunosorbent assay kits. Serum IGF-1 levels were found to be statistically significantly higher in the ASD group than in the control group. Serum HIF-1 alpha levels were borderline significantly lower in the ASD group. There was no statistically significant difference in serum VEGF levels between the two groups. IGF-1 and HIF-1 alpha may play a potential role in the etiopathogenesis of ASD. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Comparison of Serum VEGF, IGF-1, and HIF-1 alpha Levels in Children with Autism Spectrum Disorder and Healthy Controls |
|
| dc.type |
info:eu-repo/semantics/article |
|